Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Pharmacological Comparison of Native Mitochondrial KATP Channels with Molecularly Defined Surface KATP Channels

Yongge Liu, Guifen Ren, Brian O'Rourke, Eduardo Marbán and Jegatheesan Seharaseyon
Molecular Pharmacology February 2001, 59 (2) 225-230; DOI: https://doi.org/10.1124/mol.59.2.225
Yongge Liu
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guifen Ren
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian O'Rourke
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Marbán
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jegatheesan Seharaseyon
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Many mammalian cells have two distinct types of ATP-sensitive potassium (KATP) channels: the classic ones in the surface membrane (sKATP) and others in the mitochondrial inner membrane (mitoKATP). Cardiac mitoKATP channels play a pivotal role in ischemic preconditioning, and thus represent interesting drug targets. Unfortunately, the molecular structure of mitoKATP channels is unknown, in contrast to sKATP channels, which are composed of a pore-forming subunit (Kir6.1 or Kir6.2) and a sulfonylurea receptor (SUR1, SUR2A, or SUR2B). As a means of probing the molecular makeup of mitoKATP channels, we compared the pharmacology of native cardiac mitoKATP channels with that of molecularly defined sKATP channels expressed heterologously in human embryonic kidney 293 cells. Using mitochondrial oxidation to index mitoKATP channel activity in rabbit ventricular myocytes, we found that pinacidil and diazoxide open mitoKATPchannels, but P-1075 does not. On the other hand, 5-hydroxydecanoic acid (5HD), but not HMR-1098, blocks mitoKATP channels. Although pinacidil is a nonselective activator of expressed sKATP channels, diazoxide did not open channels formed by Kir6.1/SUR2A, Kir6.2/SUR2A (known components of cardiac sKATP channels) or Kir6.2/SUR2B. P-1075 activated all the KATP channels, except Kir6.1/SUR1 channels. Glybenclamide potently blocked all sKATP channels, but 5HD only blocked channels formed by SUR1/Kir6.1 or Kir6.2 (IC50s of 66 and 81 μM, respectively). This potency is similar to that for block of mitoKATP channels (IC50 = 95 μM). In addition, HMR-1098 potently blocked Kir6.2/SUR2A channels (IC50 = 1.5 μM), but was 67 times less potent in blocking Kir6.1/SUR1 channels (IC50 = 100 μM). Our results demonstrate that mitoKATP channels closely resemble Kir6.1/SUR1 sKATP channels in their pharmacological profiles.

Footnotes

  • Send reprint requests to: Eduardo Marbán, M.D., Ph.D., Institute of Molecular Cardiobiology, Johns Hopkins University, 844 Ross Building, 720 Rutland Ave., Baltimore, MD 21205. E-mail:marban{at}jhmi.edu

  • Supported by National Institutes of Health Grants R37-HL36957 (to E.M.) and T32-HL09586 (to J.S.). E.M. holds the Michel Mirowski, M.D., Professorship of Cardiology of the Johns Hopkins University.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 59 (2)
Molecular Pharmacology
Vol. 59, Issue 2
1 Feb 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Comparison of Native Mitochondrial KATP Channels with Molecularly Defined Surface KATP Channels
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Pharmacological Comparison of Native Mitochondrial KATP Channels with Molecularly Defined Surface KATP Channels

Yongge Liu, Guifen Ren, Brian O'Rourke, Eduardo Marbán and Jegatheesan Seharaseyon
Molecular Pharmacology February 1, 2001, 59 (2) 225-230; DOI: https://doi.org/10.1124/mol.59.2.225

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Pharmacological Comparison of Native Mitochondrial KATP Channels with Molecularly Defined Surface KATP Channels

Yongge Liu, Guifen Ren, Brian O'Rourke, Eduardo Marbán and Jegatheesan Seharaseyon
Molecular Pharmacology February 1, 2001, 59 (2) 225-230; DOI: https://doi.org/10.1124/mol.59.2.225
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics